Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""INFLUENZA"" wg kryterium: Temat


Starter badań:

Tytuł :
An influenza A (H3N2) virus outbreak in the Kingdom of Cambodia during the COVID-19 pandemic of 2020.
Autorzy :
Sovann LY; Ministry of Health, Cambodia.
Sar B; United States Centers for Disease Control and Prevention.
Kab V; World Health Organization, Cambodia.
Yann S; Virology Unit, Institute Pasteur of Cambodia, Cambodia.
Kinzer M; United States Centers for Disease Control and Prevention.
Raftery P; World Health Organization, Cambodia.
Albalak R; United States Centers for Disease Control and Prevention.
Patel S; World Health Organization, Cambodia.
Hay PL; World Health Organization, Cambodia.
Seng H; Ministry of Health, Cambodia.
Um S; Ministry of Health, Cambodia.
Chin S; Ministry of Health, Cambodia.
Chau D; Ministry of Health, Cambodia.
Khalakdina A; World Health Organization, Cambodia.
Karlsson E; Virology Unit, Institute Pasteur of Cambodia, Cambodia.
Olsen SJ; United States Centers for Disease Control and Prevention.
Mott JA; United States Centers for Disease Control and Prevention. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Feb; Vol. 103, pp. 352-357. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A Virus, H3N2 Subtype*/genetics
COVID-19/*epidemiology
Influenza, Human/*epidemiology
Adolescent ; Adult ; Cambodia/epidemiology ; Child ; Disease Outbreaks ; Female ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza Vaccines/administration & dosage ; Influenza, Human/virology ; Male ; Middle Aged ; Pandemics ; Real-Time Polymerase Chain Reaction ; SARS-CoV-2 ; Sentinel Surveillance ; Young Adult
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged ≥ 65 years.
Autorzy :
Kim TH; Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.
Choi JH; Division of Infectious Diseases, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: .
Park SH; Division of Infectious Diseases, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Yoo JH; Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee DG; Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Choi SM; Division of Infectious Diseases, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim YR; Division of Infectious Diseases, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee MS; Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Choo EJ; Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.
Choi HJ; Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 16; Vol. 39 (27), pp. 3621-3625. Date of Electronic Publication: 2021 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Aged ; Antibodies, Viral ; Healthy Volunteers ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity, Vaccine ; Influenza A Virus, H3N2 Subtype ; Influenza B virus ; Seasons ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł :
Reduced Influenza B-Specific Postvaccination Antibody Cross-reactivity in the B/Victoria Lineage-Predominant 2019/20 Season.
Autorzy :
Xie H; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Xiang R; Division of Biostatistics, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Wan HJ; Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, Missouri, USA.; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
Plant EP; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Radvak P; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Kosikova M; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Li X; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zoueva O; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Ye Z; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Wan XF; Center for Research on Influenza Systems Biology (CRISB), University of Missouri, Columbia, Missouri, USA.; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.; Department of Electrical Engineering and Computer Science, College of Engineering, University of Missouri, Columbia, Missouri, USA.; Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 01; Vol. 72 (11), pp. e776-e783.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Influenza Vaccines*
Influenza, Human*
Adult ; Antibodies, Viral ; Hemagglutination Inhibition Tests ; Humans ; Influenza A Virus, H3N2 Subtype ; Influenza B virus ; Phylogeny ; Seasons
Czasopismo naukowe
Tytuł :
Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine.
Autorzy :
Li J; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China.
Liu S; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China.
Gao Y; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China.; School of Computing, Urban Sciences Building, Newcastle University, 1 Science Square, Newcastle Helix, Newcastle upon Tyne, NE4 5TG, UK.
Tian S; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China.
Yang Y; School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China. .
Ma N; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, Liaoning Province, China. .
Pokaż więcej
Źródło :
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2021 May; Vol. 105 (9), pp. 3559-3572. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*
Animals ; Chick Embryo ; Chickens ; Dogs ; Glycosylation ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Hemagglutinins ; Humans ; Influenza A Virus, H3N2 Subtype/metabolism ; Madin Darby Canine Kidney Cells ; Seasons
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
Autorzy :
Wang Y; Henan Provincial Centre for Disease Control and Prevention, Zhenzhou, Henan, China.
Zhang Y; Department of Quality Control, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Wu H; Department of Research and Development, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Huang L; Henan Provincial Centre for Disease Control and Prevention, Zhenzhou, Henan, China.
Yu H; Department of Quality Control, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Xie Z; Henan Provincial Centre for Disease Control and Prevention, Zhenzhou, Henan, China.
Zhang H; Department of Quality Control, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Zhang W; Henan Provincial Centre for Disease Control and Prevention, Zhenzhou, Henan, China.
Chen X; Department of Quality Control, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Zhang H; Department of Research and Development, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Zhang H; Department of Research and Development, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Jia C; Department of Research and Development, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China.
Xia S; Henan Provincial Centre for Disease Control and Prevention, Zhenzhou, Henan, China. Electronic address: .
Wang S; Department of Research and Development, Ab&B Biotech Co., Ltd, Taizhou, Jiangsu, China; Department of Research and Development, Yither Biotech Co., Ltd, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 29; Vol. 39 (29), pp. 3871-3878. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*/adverse effects
Influenza, Human*/prevention & control
Antibodies, Viral ; China ; Double-Blind Method ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity, Vaccine ; Infant ; Influenza A Virus, H3N2 Subtype ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł :
The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
Autorzy :
Chan YW; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region. Electronic address: .
Wong ML; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region.
Kwok FY; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region.
Au AK; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region.
Leung EC; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region.
Chuang SK; Communicable Disease Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 08; Vol. 39 (25), pp. 3372-3378. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Case-Control Studies ; Hong Kong/epidemiology ; Humans ; Influenza A Virus, H3N2 Subtype ; Pandemics ; Primary Health Care ; SARS-CoV-2 ; Seasons ; Vaccination
Czasopismo naukowe
Tytuł :
Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
Autorzy :
Leung VKY; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Fox A; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Carolan LA; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Aban M; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Laurie KL; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Druce J; Victorian Infectious Disease Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Deng YM; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Slavin MA; Victorian Infectious Disease Service, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Marshall C; Victorian Infectious Disease Service, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Infection Prevention and Surveillance Service, Royal Melbourne Hospital, Melbourne, Australia; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Sullivan SG; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Fielding School of Public Health, University of California, Los Angeles, USA; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 02; Vol. 39 (24), pp. 3270-3278. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza Vaccines*
Influenza, Human*/prevention & control
Antibodies, Viral ; Antibody Formation ; Australia/epidemiology ; Health Personnel ; Humans ; Influenza A Virus, H3N2 Subtype ; Vaccination
Czasopismo naukowe
Tytuł :
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.
Autorzy :
Guthmiller JJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA. .
Han J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Li L; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Freyn AW; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Liu STH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Stovicek O; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Stamper CT; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
Dugan HL; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
Tepora ME; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Utset HA; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Bitar DJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Hamel NJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Changrob S; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Zheng NY; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Huang M; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. .
Wilson PC; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA. .; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
Pokaż więcej
Źródło :
Science translational medicine [Sci Transl Med] 2021 Jun 02; Vol. 13 (596).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*
Antibodies, Neutralizing ; Antibodies, Viral ; Broadly Neutralizing Antibodies ; Epitopes ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Humans ; Influenza A Virus, H3N2 Subtype
Czasopismo naukowe
Tytuł :
Emerging H5N8 avian influenza viruses.
Autorzy :
Shi W; School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan 250000, China. .; Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian 271000, China.
Gao GF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. .; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 May 21; Vol. 372 (6544), pp. 784-786.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H5N8 Subtype*/genetics
Influenza A Virus, H5N8 Subtype*/isolation & purification
Influenza A Virus, H5N8 Subtype*/pathogenicity
Reassortant Viruses*/classification
Reassortant Viruses*/genetics
Reassortant Viruses*/pathogenicity
Communicable Diseases, Emerging/*epidemiology
Influenza in Birds/*epidemiology
Influenza, Human/*epidemiology
Viral Zoonoses/*epidemiology
Animal Migration ; Animals ; Birds ; Communicable Diseases, Emerging/transmission ; Communicable Diseases, Emerging/virology ; Genetic Drift ; Germany/epidemiology ; Humans ; Influenza in Birds/transmission ; Influenza in Birds/virology ; Influenza, Human/transmission ; Influenza, Human/virology ; Phylogeny ; Public Health ; Russia/epidemiology ; Viral Zoonoses/virology
Czasopismo naukowe
Tytuł :
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
Autorzy :
Choreño-Parra JA; Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Jiménez-Álvarez LA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ramírez-Martínez G; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Cruz-Lagunas A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Thapa M; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
Fernández-López LA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Carnalla-Cortés M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.
Choreño-Parra EM; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Mena-Hernández L; Department of Dermatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Sandoval-Vega M; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Hernández-Montiel EM; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Hernández-García DL; Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ramírez-Noyola JA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Reyes-López CE; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Domínguez-Faure A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Zamudio-López GY; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Márquez-García E; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Moncada-Morales A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Mendoza-Milla C; Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias Isamel Cosío Villegas, Mexico City, Mexico.
Cervántes-Rosete D; Deparment of Immunology and Reumathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Muñoz-Torrico M; Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Luna-Rivero C; Department of Pathology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
García-Latorre EA; Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Guadarrama-Ortíz P; Centro Especializado en Neurocirugía y Neurociencias México (CENNM), Mexico City, Mexico.
Ávila-Moreno F; Biomedicine Research Unit, Lung Diseases and Cancer Epigenomics Laboratory, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Domínguez-Cherit G; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.; Intensive Care Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rodríguez-Reyna TS; Deparment of Immunology and Reumathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mudd PA; Department of Emergency Medicine, Washington University School of Medicine in St Louis, Missouri, USA.
Hernández-Cárdenas CM; Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Khader SA; Department of Molecular Microbiology, Washington University School of Medicine in St Louis, Missouri, USA.
Zúñiga J; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jul 02; Vol. 224 (1), pp. 21-30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression*
Influenza A Virus, H1N1 Subtype*
SARS-CoV-2*
COVID-19/*genetics
Host-Pathogen Interactions/*genetics
Influenza, Human/*genetics
Pulmonary Surfactant-Associated Protein D/*genetics
Adult ; Aged ; Biomarkers ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; Coinfection ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Influenza, Human/diagnosis ; Influenza, Human/virology ; Male ; Middle Aged ; Prognosis ; Pulmonary Surfactant-Associated Protein D/blood ; Severity of Illness Index ; Symptom Assessment ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of Influenza Vaccination in Preventing Laboratory-Confirmed Influenza Hospitalization in Patients With Diabetes Mellitus.
Autorzy :
Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navascués A; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Portillo ME; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Casado I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Fresán U; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Ezpeleta C; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. 107-114.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus*/epidemiology
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/complications
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Aged ; Case-Control Studies ; Hospitalization ; Humans ; Influenza A Virus, H3N2 Subtype ; Laboratories ; Seasons ; Spain/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
Autorzy :
Stuurman AL; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. Electronic address: .
Biccler J; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. Electronic address: .
Carmona A; FISABIO Public Health, Valencia, Spain. Electronic address: .
Descamps A; Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, France. Electronic address: .
Díez-Domingo J; FISABIO Public Health, Valencia, Spain. Electronic address: .
Muñoz Quiles C; FISABIO Public Health, Valencia, Spain. Electronic address: .
Nohynek H; Finnish Institute for Health and Welfare, Helsinki, Finland. Electronic address: .
Rizzo C; Bambino Gesù Children's Hospital, Rome, Italy. Electronic address: .
Riera-Montes M; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. Electronic address: .
Pokaż więcej
Corporate Authors :
DRIVE Public Partners
Źródło :
Vaccine [Vaccine] 2021 Jun 29; Vol. 39 (29), pp. 3964-3973. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Adult ; Austria ; Case-Control Studies ; Child ; Cohort Studies ; England ; Europe/epidemiology ; Finland ; France ; Humans ; Influenza A Virus, H3N2 Subtype ; Italy ; Pandemics ; Romania ; SARS-CoV-2 ; Seasons ; Spain ; Vaccination
Czasopismo naukowe
Tytuł :
Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011.
Autorzy :
Niang MN; Institut Pasteur de Dakar, Dakar, Senegal.
Sugimoto JD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Seattle Epidemiologic Research and Information Center, Department of Veterans Affairs Office of Research and Development, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Diallo A; VITROME, Institut de Recherche Pour le Développement, Dakar, Senegal.
Diarra B; VITROME, Institut de Recherche Pour le Développement, Dakar, Senegal.
Ortiz JR; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Lewis KDC; PATH, Seattle, Washington, USA.
Lafond KE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Halloran ME; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Widdowson MA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Institute of Tropical Medicine, Antwerp, Belgium.
Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Victor JC; PATH, Seattle, Washington, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 15; Vol. 72 (12), pp. e959-e969.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Child ; Humans ; Influenza A Virus, H3N2 Subtype ; Randomized Controlled Trials as Topic ; Senegal/epidemiology ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł :
Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
Autorzy :
Powell H; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, United States.
Liu H; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, United States.
Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 02; Vol. 39 (24), pp. 3225-3235. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Influenza Vaccines*
Influenza, Human*
Animals ; Chickens ; Epithelial Cells ; Female ; Humans ; Influenza A Virus, H3N2 Subtype ; N-Acetylneuraminic Acid ; Vaccines, Attenuated ; Virus Replication
Czasopismo naukowe
Tytuł :
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
Autorzy :
Correia R; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.
Meneses L; , Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
Richheimer C; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal.
Alves PM; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.
Carrondo MJT; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal.
Duarte ARC; , Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
Paiva A; , Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
Roldão A; IBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal; ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 02; Vol. 39 (24), pp. 3279-3286. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza Vaccines*
Influenza, Human*
Vaccines, Virus-Like Particle*
Antibodies, Viral ; Glycerol ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Humans ; Solvents ; Trehalose
Czasopismo naukowe
Tytuł :
Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness.
Autorzy :
Kaku N; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan. Electronic address: .
Kodama H; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Akamatsu N; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Ota K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Kosai K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Morinaga Y; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Microbiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama City, Toyama, Japan.
Narita Y; Narita Naika Clinic, 2026-6 Yoshimuta-go, Nagayo cho, Nishisonogi-gun, Nagasaki, Japan.
Matsumoto Y; Matsumoto Naika, 257-1 Kohjiroki, Kunimi-cho, Unzen City, Nagasaki, Japan.
Matsushita T; Shinzato Medicare Group Shinzato Clinic, 3-20 Mori-machi, Nagasaki City, Nagasaki, Japan.
Mizuta Y; Menoto Hosiptal, 849-18 Koda-go, Nagayo cho, Nishisonogi-gun, Nagasaki, Japan.
Izumikawa K; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Yanagihara K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Jun; Vol. 27 (6), pp. 820-825. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Influenza A virus*/genetics
Influenza, Human*/diagnosis
Orthomyxoviridae*/genetics
Respiratory Syncytial Virus Infections*/diagnosis
Adult ; Humans ; Immunoassay ; Influenza B virus/genetics ; Japan ; Point-of-Care Systems ; Point-of-Care Testing ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Multivalent Affinity Profiling: Direct Visualization of the Superselective Binding of Influenza Viruses.
Autorzy :
Overeem NJ; Department of Molecules & Materials, MESA+ Institute for Nanotechnology, Faculty of Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands.
Hamming PHE; Department of Molecules & Materials, MESA+ Institute for Nanotechnology, Faculty of Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands.
Tieke M; Division of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands.
van der Vries E; Division of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands.; Royal GD, Arnsbergstraat 7, 7418 EZ, Deventer, The Netherlands.; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Huskens J; Department of Molecules & Materials, MESA+ Institute for Nanotechnology, Faculty of Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands.
Pokaż więcej
Źródło :
ACS nano [ACS Nano] 2021 May 25; Vol. 15 (5), pp. 8525-8536. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A virus*
Influenza, Human*
Hemagglutinin Glycoproteins, Influenza Virus ; Humans ; Neuraminidase
Czasopismo naukowe
Tytuł :
Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.
Autorzy :
Mori K; Department of Microbiology, Kawasaki Medical School, Okayama, Japan .
Ohniwa RL; Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.; Center for Biotechnology, National Taiwan University, Taipei, Taiwan.
Takizawa N; Laboratory of Virology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Naito T; Department of Microbiology, Kawasaki Medical School, Okayama, Japan.
Saito M; Department of Microbiology, Kawasaki Medical School, Okayama, Japan .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2021 May 24; Vol. 95 (12). Date of Electronic Publication: 2021 May 24 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza Vaccines*
Influenza A virus/*genetics
Influenza A virus/*physiology
RNA-Dependent RNA Polymerase/*metabolism
Viral Proteins/*genetics
Amino Acid Substitution ; Animals ; Antiviral Agents/pharmacology ; Dogs ; Drug Resistance, Viral ; Influenza A virus/drug effects ; Madin Darby Canine Kidney Cells ; Mutation ; Phenotype ; Protein Engineering ; RNA-Dependent RNA Polymerase/chemistry ; Ribavirin/pharmacology ; Vaccines, Attenuated ; Viral Plaque Assay ; Viral Proteins/chemistry ; Viral Proteins/metabolism
Czasopismo naukowe
Tytuł :
Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh.
Autorzy :
Kwon JH; U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA; College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Criado MF; U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA; Current address: Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.
Killmaster L; U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA.
Ali MZ; National Reference Laboratory for Avian Influenza, Animal Health Research Division, Bangladesh Livestock Research Institute, Savar, Dhaka 1341, Bangladesh.
Giasuddin M; National Reference Laboratory for Avian Influenza, Animal Health Research Division, Bangladesh Livestock Research Institute, Savar, Dhaka 1341, Bangladesh.
Samad MA; National Reference Laboratory for Avian Influenza, Animal Health Research Division, Bangladesh Livestock Research Institute, Savar, Dhaka 1341, Bangladesh.
Karim MR; National Reference Laboratory for Avian Influenza, Animal Health Research Division, Bangladesh Livestock Research Institute, Savar, Dhaka 1341, Bangladesh.
Brum E; Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dhaka 1341, Bangladesh.
Hasan MZ; Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dhaka 1341, Bangladesh.
Lee DH; Department of Pathobiology and Veterinary Science, the University of Connecticut, Storrs, CT 06269, USA.
Spackman E; U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA.
Swayne DE; U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 May 18; Vol. 39 (21), pp. 2824-2832. Date of Electronic Publication: 2021 Apr 25.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Influenza A Virus, H5N1 Subtype*
Influenza Vaccines*
Influenza in Birds*/prevention & control
Animals ; Bangladesh/epidemiology ; Chickens ; Hemagglutinin Glycoproteins, Influenza Virus/genetics
Czasopismo naukowe
Tytuł :
Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study.
Autorzy :
Cheng Y; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Ma J; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Wang H; Department of Radiology, Peking University First Hospital, Beijing, China.
Wang X; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Hu Z; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Li H; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Zhang H; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Liu X; Department of Geriatric Medicine, Peking University First Hospital, Beijing, China.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 May; Vol. 93 (5), pp. 2947-2954. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A virus*
SARS-CoV-2*
COVID-19/*epidemiology
Coinfection/*epidemiology
Influenza, Human/*epidemiology
Aged ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/physiopathology ; China/epidemiology ; Coinfection/complications ; Coinfection/virology ; Cytokines/blood ; Female ; Humans ; Immunoglobulin M/blood ; Influenza, Human/complications ; Influenza, Human/diagnosis ; Influenza, Human/physiopathology ; Male ; Middle Aged ; Pandemics ; Retrospective Studies ; Seasons
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies